Navigation Links
Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results
Date:4/9/2009

cal trial application with the SFDA in 2009 in order to commence human dosing. The Company holds the development rights to this first-of-its-kind vaccine and intends to submit the patent application for this vaccine in China in 2009. We anticipate that this vaccine should become a flagship product given the severity of recent hand, foot and mouth disease outbreak in China and other countries. As the developer of a vaccine against hand, foot and mouth disease, Sinovac is well positioned to address this global unmet medical need as cases continue to be reported in China and neighboring countries. Sinovac is proud to take a leadership position, as we did with Panflu, to benefit China and the world by developing and manufacturing high quality, novel vaccines," concluded Mr. Yin.

Twelve Months Ended December 31, 2008

For the twelve months ended December 31, 2008, sales reached $46.5 million, compared to $33.5 million for the full year 2007, representing 39% growth.

During the twelve months ended December 31, 2008, Sinovac sold 6.93 million doses of Healive, compared to 5.12 million doses for the same period in 2007. Sinovac sold 1.56 million doses of Anflu during the full year 2008, compared to 1.59 million doses for the same period of the prior year. The Company sold 255,000 doses of Bilive during the 2008 period, compared to 15,684 doses in the prior year period. For the first twelve months of 2008, Healive, Anflu, and Bilive as a percentage of sales represented 88%, 9% and 3%, respectively.

Gross profit for twelve months ended December 31, 2008 was $36.6 million, with a gross margin of 79%, compared to $27.0 million, or 81%, for the same period of 2007.

Total operating expenses for the twelve months ended December 31, 2008 were $21 million, compared to $13.6 million for the same period 2007. Selling, general and administrative expenses for the twelve months ended Decembe
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Sinovac Announces Postponement of Annual General Meeting
2. Sinovac Requests Extension for Annual Shareholders Meeting
3. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
4. Sinovac Closes $9.75 Million Private Placement
5. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
6. Sinovac Announces Adjournment of Annual General Meeting
7. Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2007 Financial Results
8. Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results
9. Sinovac Biotech Holds Annual General Meeting
10. Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008
11. Sinovac Receives RMB 20 Million Purchase Order for Healive from Chinas Ministry of Health to Vaccinate Earthquake Victims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... August 01, 2014 Once a decision ... cost? This webinar will discuss how to define your ... Join speakers Bob Allen, Senior Director of Facilities Integration ... Engineering at Fluor Industrial Services, and special guest Carrier ... Planning at Amgen, as they provide an examination of ...
(Date:8/1/2014)... Aug. 1, 2014 Glencoe Software, ... of "Data InPress" ( http://glencoesoftware.com/data-inpress.html ), a ... multidimensional image data into on-line publications.  The ... Video Injection Service. Photo - ... http://photos.prnewswire.com/prnh/20140731/132409 The DataViewer ...
(Date:7/31/2014)... “2014 Deep Research Report ... is a professional and in-depth research report ... Polyurethane Resin basic information, including its definition, ... industry overview. This research covers the international ... well as global industry analysis covering macroeconomic ...
(Date:7/31/2014)... not donor candidates for bone marrow transplantation. The immune ... prone to life-threatening infection and other maladies, and a ... reason why. , "We have found the cellular mechanism ... blood production over time in an old organism, and ... rejuvenation therapies," said Emmanuelle Passegu, PhD, a professor of ...
Breaking Biology Technology:Defining Low Cost in Your Solution for Future Facilities, New Webinar for Pharma, Biotech, Medical Device and Healthcare Companies, Hosted by Xtalks 2Glencoe Software Launches Data InPress 2Glencoe Software Launches Data InPress 3Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 2Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 3Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 4Key to aging immune system is discovered 2
... practical use of visible light and zinc oxide nanorods ... by researchers at the Asian Institute of Technology (AIT). ... energy have been found to be effective in killing ... finding that has immense possibilities for affordable and environmentally ...
... of the Sciences Board of Trustees today elected Marvin ... R. Howard, CEO of Advanced Pharmacy Services, vice chairman. ... chair Dr. Delbert S. Payne, who was subsequently elected ... world-renowned leader in injectable manufacturing and delivery systems, Samson ...
... CHICO, Calif., May 12, 2011 Dan Neumeister, FACHE, ... healthcare management services firm, has been selected by Chase ... as interim chief executive officer (CEO) effective May 1, ... health center,s CEO Search Committee permanently fills the position. ...
Cached Biology Technology:Exposing ZnO nanorods to visible light removes microbes 2USciences Board of Trustees Elects Marvin Samson Chairman and Richard R. Howard Vice Chairman 2Regional Healthcare Management Firm Goes National 2
(Date:7/31/2014)... ago, prestin was found to be a key gene responsible ... in the hair cells of the inner ear that contracts ... like an antique phonograph horn, amplify sound waves to make ... published in the advanced online edition of Molecular Biology ... prestin has also independently evolved to play a critical role ...
(Date:7/31/2014)... GAINESVILLE, Fla. --- By tracing nearly 3,000 genes ... moths, University of Florida scientists have created an ... to use large-scale, next-generation DNA sequencing. , ... more closely related to small moths than to ... how butterflies evolved. The study also found that ...
(Date:7/31/2014)... studied 100 twin pairs have identified a gene mutation that ... six hours of sleep per night. The genetic variant ... sleep deprivation. , Results show that a participant with p.Tyr362His ... average nightly sleep duration of only five hours, which was ... slept for about six hours and five minutes per night. ...
Breaking Biology News(10 mins):UF study advances 'DNA revolution,' tells butterflies' evolutionary history 2UF study advances 'DNA revolution,' tells butterflies' evolutionary history 3Study of twins discovers gene mutation linked to short sleep duration 2
... review article by researchers at Boston University School of ... high blood pressure, is the result of excess salt ... the arteries. Published online in the Journal of ... the sympathetic nervous system to produce adrenalin, causing artery ...
... today in PLoS ONE entitled, Zoonotic ... a collaborative study led by the U.S. Centers ... of retroviruses and herpesviruses in illegally imported wildlife ... John F. Kennedy International Airport, George Bush Intercontinental-Houston ...
... (UCSF) has signed an alliance with international pharmaceutical company ... in diabetes research and identify drug targets that could ... type 2 diabetes. The $3.1 million collaboration will ... understanding of the biology of beta cells insulin-producing ...
Cached Biology News:Boston University School of Medicine researchers clarify link between salt and hypertension 2Study establishes importance of tracking diseases associated with illegal wildlife trade 2Study establishes importance of tracking diseases associated with illegal wildlife trade 3UCSF, Sanofi collaborate to find new diabetes cures 2UCSF, Sanofi collaborate to find new diabetes cures 3
... Software reads and processes raw ... microarray data for analysis. ... one 2-year license for Feature ... , * one CD-ROM ...
... and SYBR Safe DNA Gel Stain combo offers these ... buying these same products separately ... bromide Eliminates risks to ... and RNA fragments from 100 bp to >30 kb. ...
Anti-WT-1 Liquid. In 10 μM PBS, 0.2 % BSA, pH 7.6. Recognizes the ~47-55 kDa Wilm's tumor protein in Wilm's tumor tissue. ...
... The economical ICS-90 uses continuous chemical ... to give you fast, accurate determinations of ... ranges. Easy to operate, quick to equilibrate, ... the compact ICS-90 helps you achieve maximum ...
Biology Products: